The recognition follows a rigorous evaluation of more than 4,000 instruments used by laboratory professionals nationwide. These awards reinforce a market position Werfen has held since 2018, validating the firm's focus on its Hemostasis portfolio, which includes the ACL TOP 70 Series and HemoCell lab automation systems. According to Richa Singh, Vice President of Strategic Insights at IMV, the results are derived from independent, data-driven research that serves as a primary benchmark for laboratory equipment reliability.
Bill Crandell, Werfen’s Vice President of North America Commercial Operations, attributed the sweep to the coordinated efforts of the company's design, manufacturing, and support teams. The ServiceTrak program, which has tracked diagnostic trends for over 25 years, evaluates 38 distinct attributes to determine manufacturer rankings. For hospitals and independent labs, these metrics offer a clear indicator of system uptime and the quality of technical support provided by diagnostic suppliers.
Comments (0)
No comments yet. Be the first!